Top Markets
#1 0G 0G +34.27%
#2 Nockchain Nockchain +23.06%
#3 Axelar Axelar +21.57%
#4 Fake World Assets Fake World Assets +19.15%
#5 Full Moon Full Moon +17.70%
#6 Zora Zora +17.54%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.09%
#8 Notcoin Notcoin +16.06%
#9 ADO Protocol ADO Protocol +15.57%
#10 StonkBroker StonkBroker +15.35%
Coin of the day
0G 0G
設定
言語
日本
通貨
USD
テーマ
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
株式のランク #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
株価
$8.46
最終同期: 2026-08-28
時価総額
$514.33M
変化（1日）
-2.08%
変化（1年）
128.03%
国
US
取引 Kyverna Therapeutics, Inc. (KYTX)

カテゴリー

Healthcare
Kyverna Therapeutics, Inc.（KYTX）のP/S比率
2026 時点のP/S比率 TTM: 0
Kyverna Therapeutics, Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 0 です。2026 年末時点でのP/S比率は 0 でした。
Kyverna Therapeutics, Inc. の P/S 比率の履歴（2026 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH